The use of a recombinant bacterial vector vaccine is an attractive vaccination strategy to induce an immune response to a carried protective antigen. The superiorities of live bacterial vectors include mimicry of a natural infection, intrinsic adjuvant properties, and the potential for administration by mucosal routes. Escherichia coli is a simple and efficient vector system for production of exogenous proteins. In addition, many strains are nonpathogenic and avirulent, making it a good candidate for use in recombinant vaccine design. In this study, we screened 23 different iron-regulated promoters in an E. coli BL21(DE3) vector and found one, P viuB , with characteristics suitable for our use. We fused P viuB with lysis gene E, establishing an in vivo inducible lysis circuit. The resulting in vivo lysis circuit was introduced into a strain also carrying an IPTG (isopropyl-␤-Dthiogalactopyranoside)-inducible P T7 -controlled protein synthesis circuit, forming a novel E. coli-based protein delivery system. The recombinant E. coli produced a large amount of antigen in vitro and could deliver the antigen into zebrafish after vaccination via injection. The strain subsequently lysed in response to the iron-limiting signal in vivo, implementing antigen release and biological containment. The gapA gene, encoding the protective antigen GAPDH (glyceraldehyde-3-phosphate dehydrogenase) from the fish pathogen Aeromonas hydrophila LSA34, was introduced into the E. coli-based protein delivery system, and the resultant recombinant vector vaccine was evaluated in turbot (Scophtalmus maximus). Over 80% of the vaccinated fish survived challenge with A. hydrophila LSA34, suggesting that the E. coli-based antigen delivery system has great potential in bacterial vector vaccine applications.
Bacterial delivery of protein antigens has great potential due to the low cost of production and mucosal delivery. Two distinct approaches have been used when identifying specific bacterial delivery vectors, attenuated pathogens and commensals. These approaches are based on particular qualities that are unique to live bacteria. Many attenuated pathogenic bacteria can replicate in the host to some extent, with attributes such as cellular tropism, cell-to-cell spreading, and dissemination, resulting in strong humoral and cellular immunity. Furthermore, they can migrate to immune-inductive cells, carrying with them lipopolysaccharide or unmethylated CpG motifs as adjuvants, which are immune stimulatory macromolecules supporting a strong immune response (36) . Representative attenuated pathogens include Salmonella enterica serovars Typhi and Typhimurium (17, 18, 23, 41) , Shigella (3), Listeria monocytogenes (31) , and Yersinia enterocolitica (33) . Given the concern for biosafety, commensals have also been tested as antigen delivery vectors. Nonpathogenic Escherichia coli and foodgrade Lactococcus lactis are the best cases, with accepted safety, cost-effectiveness, and minimal side effects (51, 52, 55) .
An important quality of a live bacterial vector is its ability to present sufficient foreign antigen to the immune system to initiate the desired protective immune response(s) (16) . Several approaches have been used to improve antigen delivery by bacterial vectors, including modification of the bacterial vector for better proficiency in invasion and colonization of deep effector lymphoid tissues and optimization of antigen expression for increased exposure of antigen to the host immune system by antigen secretion or antigen surface display. With respect to bacterial vector modification, to maintain the invasive abilities of attenuated Salmonella, Roy Curtiss III and colleagues have adopted an in vivo regulated delayed-attenuation strategy, such that the vaccine, at the time of immunization, exhibits almost the same abilities as a fully virulent wildtype strain to contend with stresses and successfully reach effector lymphoid tissues before display of attenuation to preclude onset of any disease symptoms (13) . In other studies, nonpathogenic E. coli strains were genetically modified to be invasive by expressing the inv gene from Yersinia pseudotuberculosis, which conferred the ability to invade nonprofessional phagocytic cells, and the hly gene from Listeria monocytogenes, which allowed expression of listeriolysin O, a perforin cytolysin able to disrupt phagosomal membranes (8) . Using such an invasive E. coli strain, efficient and stable protein transfer was observed after coincubation of bacteria with various macrophage or epithelial cell lines (12) . However, a major limitation of these kinds of enhancements is the potential biological security concern regarding invasive bacteria in the animal host and the environment.
With respect to antigen expression optimization, Georgiou et al. (22) developed an efficient surface display system, LppOmpA, which was used successfully to anchor different protein antigens onto the cell surface (27) . Alternatively, antigen can be directly introduced into the host cell via the type III secre-tion system of Yersinia or Salmonella, which elicits strong cellular immune responses (21, 36) . Other strategies include the use of type I (21, 36) and type II (28) secretion systems to enhance antigen delivery and immunogenicity. Despite the promise of both surface display and secretion, there are potential problems with both strategies. For instance, antigen surface display is usually hindered by a low display efficiency, which is presumably due to overproduction of the display protein perturbing the integrity of the outer membrane (56) . Antigen secretion systems are often limited by the size of the polypeptide exported (16) .
Over the past 5 years, we have been working on the design of recombinant bacterial vector vaccines. Our work has been focused on antigen display and secretion systems in the attenuated pathogen Vibrio anguillarum (15, 67) . Recently we have concentrated our efforts on establishing a bacterial delivery system in which the vector bacteria could produce a large amount of intracellular antigen in vitro, and after being administrated into a host, the resulting strain would lyse efficiently in response to a specific in vivo signal to implement antigen release and biological containment. Based on this delivery model, two key elements need to be established: an in vivo-inducible regulation circuit and an efficient bacteria lysis factor.
Several in vivo-inducible promoters which respond to environmental stimuli in vivo, such as anaerobic conditions (54) , oxidizing agent availability (10) , and low magnesium (20) or iron concentrations, have been investigated previously. Although iron is one of the most abundant metals on earth, it is often bound to metal-chelating proteins in vivo, and thus the availability of free iron is extremely limited in hosts (5) . Therefore, a low free iron concentration serves as an in vivo environmental signal (50) . To adapt to the iron starvation conditions present in the host, bacteria have evolved various iron uptake, storage, and metabolism systems to acquire and utilize iron in this environment. Among them, a typical iron uptake regulon has been well described, in which the ferric uptake regulator protein (Fur) acts as a repressor for a number of genes involved in iron uptake, storage, and metabolism upon interaction with its corepressor, Fe 2ϩ , and no longer represses those genes in the absence of Fe 2ϩ (2) . Many iron-regulated promoters have been identified, such as P suf from E. coli (49) , P hutA from Vibrio cholerae (24) , and P fatD from V. anguillarum (1), but thus far, none of them has been applied to build an in vivo-inducible regulation circuit for use in a bacterial vector vaccine.
Many bacterium-killing proteins have been identified, including porin-inducing protein Gef (30) , bacterial toxin E3 (63) , and EcoRI restriction endonuclease (62) . One of the most widely studied killing factors is the lysis protein E from bacteriophage X174 which is encoded by gene E. Protein E is a 91-amino-acid membrane protein that fuses the inner and outer membranes of Gram-negative bacteria, forming an Especific lysis tunnel to expel the cytoplasmic contents. The remaining empty internal lumens of bacteria, largely devoid of nucleic acids, ribosomes, or other constituents, are called bacterial ghosts (38) . E-mediated lysis has been shown to be fatal in a wide range of Gram-negative bacteria, such as S. enterica serovar Typhimurium, S. enterica serovar Enteritidis, V. cholerae, Klebsiella pneumoniae, Bordetella bronchiseptica, Helicobacter pylori, Actinobacillus pleuropneumoniae, Pseudomonas aeruginosa, Pseudomonas putida, Ralstonia eutropha, and Erwinia cypripedii (37) . Thus, the bacteriophage X174-originated protein E appears to be an effective and broad-spectrum bacterial lysis factor.
In this work, using E. coli BL21(DE3) as a bacterial vector, a strict iron-regulated promoter, P viuB , was identified and applied to control the expression of lysis gene E, thus establishing an in vivo-inducible lysis system. An IPTG (isopropyl-␤-D-thiogalactopyranoside)-inducible P T7 -controlled antigen expression circuit was integrated into the lysis system to build a novel E. coli-based antigen delivery system. A protective antigen, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), from the important fish pathogen Aeromonas hydrophila was introduced into the delivery system, and its potential as a recombinant bacterial vector vaccine was confirmed by evaluation of immune protection in turbot.
MATERIALS AND METHODS
Bacterial strains, plasmids, and media. The bacterial strains and plasmids used in this study are listed in Table 1 . E. coli strains were grown at 37°C in lysogeny broth (LB) medium (1% tryptone, 0.5% yeast extract, 0.5% NaCl). V. anguillarum and Vibrio parahaemolyticus strains were cultured at 30°C in LB medium supplemented with 2% NaCl. When required, ampicillin (Amp) (100 g/ml), kanamycin (Km) (25 g/ml), isopropyl-␤-D-thiogalactoside (IPTG) (0.5 mM), FeSO 4 (40 M), and/or 2,2Ј-dipyridyl (200 M) was added.
Plasmid construction. The lac promoter and multiple-cloning site (MCS) of pUC18 were deleted by digestion with PvuII/NdeI and replaced with a 506-bp sequence containing the MCS and the rrnBT1T2 terminator from plasmid pBV220 to yield plasmid pUT. The 720-bp gfpuv1 gene, amplified from plasmid mTn5gusA-pgfp12, was inserted into BamHI/PstI-digested pUT to yield the promoter-screening plasmid pUTG. A series of primers were designed to amplify the candidate promoters from bacterial chromosomes or plasmids ( Table 2 ). The amplified promoter products, possessing the native start codon, Shine-Dalgarno sequence, and Ϫ35 and Ϫ10 promoter elements plus additional upstream bases, were inserted into pUTG, and the resultant plasmids were transformed into E. coli BL21(DE3) for iron-regulated promoter screening.
pUTa was constructed by replacement of the pBR322 replication origin of pUT with the p15A origin from pACYC184. The 276-bp E gene, amplified from the X174 genome, was inserted into BamHI/PstI-digested pUTa to yield pUTaE. P viuB was then ligated into EcoRI/BamHI-digested pUTaE, resulting in the iron-regulated lysis plasmid pUTaBE. The 996-bp gapA gene amplified from the A. hydrophila LSA34 chromosome was inserted into BamHI/HindIII sites of pET28a under the control of the T7 promoter, generating pETGA. Both pUTaBE and pETGA were transformed into E. coli BL21(DE3) for E lysis and antigen GAPDH expression.
Detection of GFP synthesis in iron-limiting medium. Overnight cell cultures were inoculated (1:100, vol/vol) into fresh LB medium containing appropriate antibiotics and cultured in a shaker at 200 rpm and 37°C. At early log phase, typically an optical density at 600 nm (OD 600 ) of 0.8 to 1.0, 2,2Ј-dipyridyl was added to induce the expression of green fluorescent protein (GFP). After 20 h of iron-limiting induction, a 1-ml cell culture sample was taken, centrifuged at 12,000 ϫ g for 3 min, washed, and resuspended in phosphate-buffered saline (PBS) (pH 7.2) to the same OD 600 value (OD 600 ϭ 1.0). For each sample, 100 l of cell suspension was added to a 96-well flat-bottom polystyrene plate (Costar) and measured with a fluorescence plate reader (Tecan, GENios Pro, Austria). The excitation wavelength was set at 485 nm, and emission was detected at 535 nm.
Fur titration assay. The Fur-regulated promoter carried on a multicopy plasmid can be identified by transformation into E. coli strain H1717. This strain carries a Fur-regulated fhuF::lacZ gene fusion which is particularly sensitive to changes in the concentration of the Fur repressor (58 Ϫ colonies remain white. In this experiment, the viuB promoter was inserted into the pMD19T-simple vector, and the resultant recombinant plasmid, pMD19TB, was transferred into E. coli indicator strain H1717 competent cells, producing strain E. coli H1717/ pMD19TB. At the same time, E. coli H1717 with pMD19T-simple vector (E. coli H1717/pMD19T) was used as a negative control. The overnight cell cultures were diluted to spread on MacConkey plates with 25 M FeSO 4 for colony color detection. The experiment was performed in triplicate.
Detection of GFP synthesis in vivo in zebrafish. At the beginning, an experiment was performed to test whether GFP could be produced during the process of immersion. BL21(DE3)/pUTG or BL21(DE3)/pUTBG was incubated in the immersion solution, and samples were taken from the immersion solution at regular times and adjusted to identical cell density for fluorescence detection. BL21(DE3)/pUTBG was also cultured in iron-limited LB medium to induce GFP synthesis, and the bacterial sample, adjusted to the identical cell density, was taken as the positive control for analysis.
Zebrafish were cultured in a laboratory breeding system, and their care and feeding followed established protocols (http://zfin.org/zf_info/zfbook/zfbk.html). The transparent zebrafish larvae were bred as previously described (29) . Overnight cell cultures of recombinant E. coli were inoculated (1:100, vol/vol) into fresh LB medium containing antibiotics and cultured in a shaker at 200 rpm and 37°C for 5 h, and then the cells were harvested and resuspended in phosphatebuffered saline (PBS) (pH 7.2). Zebrafish at the age of 6 to 8 days were selected and immersed in cell suspensions of E. coli BL21(DE3) and E. coli BL21(DE3)/ pUTBG at a concentration of 10 8 viable bacteria per ml for 1 h, and after being washed with PBS at least four times, the infected fish were bred in fresh water. The GFP expression in vivo in zebrafish was analyzed with an inverted fluorescence microscope and by confocal microscopy at 9 h postinfection.
For microscopy analysis, all the fish were anesthetized with MS-222 (Tricaine methanesulfonate; Sigma). An inverted fluorescence microscope (Olympus IX71 with a ϫ20 zoom magnification) was used. GFP fluorescence was detected by exposure of the fish to UV light in the excitation range of 450 to 490 nm. Images were captured using a Hamamatsu OrcaIIIm charge-coupled-device (CCD) camera. Fish were further examined with an inverted Leica TCS SP5 confocal microscope. The samples were detected using Plan Apo 20.0ϫ/0.70 water-corrected lenses. Differential interference contrast (DIC) images of the fish were first captured with the DC300 camera using Leica IM50 software, and the GFP fluorescence was then detected by scanning samples using the 488-nm argon laser line for excitation.
Assay for E. coli lysis in vitro. E. coli strains BL21(DE3)/pUTaBE and BL21(DE3)/pUTa were grown at 37°C overnight with 40 M FeSO 4 to ensure tight repression of lysis gene E. To induce E expression, the cultures were diluted to an OD 600 of 0.1 and cultured in a shaker at 200 rpm and 37°C. At early log phase (OD 600 ϭ 0.3 to 0.4), 2,2Ј-dipyridyl was added to cultures to create iron-limiting conditions. Cell samples were taken at 30 min, 60 min, 90 min, and 120 min postinduction to measure both the OD 600 and the CFU to determine the growth and lysis of the bacteria in iron-limiting medium.
The cell samples taken at 30 min and 120 min postinduction were harvested by centrifugation at 4,000 ϫ g for 15 min, washed twice in PBS (pH 7.2), and incubated with glutardialdehyde (2.5% in PBS) at 4°C for 2 h. Cells were rinsed 3 times with the same buffer and then dehydrated with a graded series of ethyl alcohol and isoamyl acetate solutions. Following the final dehydration, cells were dried with liquid CO 2 , mounted on the holder with silver paint, and sputtered with gold-palladium using a Polaron high-resolution sputter coater. All scanning electron micrographs were taken with a Hitachi S-4800 scanning electron microscope.
Assay for antigen release in E. coli in vitro. The recombinant E. coli strains BL21(DE3)/pETGAϩpUTaBE and BL21(DE3)/pETGAϩpUTa were grown in LB medium at 37°C with ampicillin, kanamycin, and FeSO 4 . At early log phase, 0.5 mM IPTG was added to induce gapA expression and the culture incubated for an additional 5 h. The cultures were then subcultured in a shaker to obtain an initial OD 600 of 0.1, and 2,2Ј-dipyridyl was added to cultures at early log phase (OD 600 ϭ 0.3 to 0.4) to induce cell lysis. After 2 h of induction for cell lysis, the supernatants and cell debris were separated by centrifugation at 4,000 ϫ g for 15 min and the two fractions were analyzed by enzyme-linked immunosorbent assay (ELISA) to quantify the antigen GAPDH. ELISA was performed in 96-well flat-bottom polyvinyl microtiter plates (Costar). The wells were coated with 100 l of each supernatant fraction and intracellular fraction by overnight incubation at 4°C. Unbound proteins were removed by washing with PBS containing 0.05% Tween 20 (PBST), and the wells were blocked with 200 l of PBST containing 1% bovine serum albumin (BSA) for 1 h at 37°C. After removal of the blocking solution and washing three times with PBST, the plate was incubated for 2 h with rabbit anti-GAPDH antibody (YingJi Technology, Shanghai, China) at a dilution of 1:50,000 (vol/vol). After three washes, the plate was incubated for another 1 h at 37°C with horseradish peroxidase-conjugated goat anti-rabbit antibody (Jackson Immuno Research Laboratories) at a dilution of 1:5,000 (vol/vol). Finally, the wells were washed three times with PBST, and tetramethylbenzidine (TMB) solution (Tiangen Biotech, Beijing, China) was added for color development. After addition of 2 M H 2 SO 4 for termination of the reaction, the OD 450 in each well was measured with a microplate reader (model 550; Bio-Rad, Hercules, CA). Analysis of bacterial lysis and antigen release in zebrafish. After 5 h of IPTG induction for GAPDH synthesis in the recombinant E. coli BL21(DE3)/ pETGAϩpUTaBE and BL21(DE3)/pETGAϩpUTa strains as described above, the cultures were washed and resuspended in PBS. A total of 180 healthy zebrafish with average weight of 2 g were selected and divided randomly into three groups. The fish in groups 1 to 3 were injected intraperitoneally (i.p.) with 5 l of PBS, E. coli BL21(DE3)/pETGAϩpUTa suspension (10 7 CFU per fish), or E. coli BL21(DE3)/pETGAϩpUTaBE suspension (10 7 CFU per fish). At 4, 9, and 24 h postadministration, 20 fish with similar weights were randomly taken from each experimental group and the tissues surrounding and including the abdominal cavities with similar size were collected; the weight of each tissue sample was kept at between 6 and 7 g. The tissue samples were then homogenized in 15 ml PBS. In order to determine the growth and lysis of E. coli in zebrafish, 1 ml of each homogenate sample was diluted serially in PBS and plated in triplicate on LB agar containing kanamycin and ampicillin to count the CFU. In addition, the remaining homogenate of each sample was centrifuged at 4,000 ϫ g for 15 min. The resulting supernatant was further concentrated to 200 l by using an Amicon Ultra-15 centrifugal filter unit (10-kDa cutoff) (Millipore). The enriched supernatant was analyzed by Western blotting, performed as described previously (67) , to assay antigen release in vivo.
Vaccination and challenge. E. coli BL21(DE3)/pETGAϩpUTaBE, E. coli BL21(DE3)/pETGAϩpUTa, and purified protein GAPDH were used as immunogens. All the vaccination and challenge experiments were independently repeated three times.
Turbot (Scophtalmus maximus) weighing approximately 10 g each were obtained from an aquaculture farm in Shandong Province, China, and were reared and acclimated for 30 days before the experiment. The recombinant E. coli BL21(DE3)/pETGAϩpUTaBE and BL21(DE3)/pETGAϩpUTa were induced to produce large amounts of GAPDH cytoplasmically as described above (see "Assay for antigen release in E. coli in vitro"), and the cell cultures were washed and resuspended in PBS for vaccination. Four groups (30 fish in each) were vaccinated by intraperitoneal (i.p.) injection with E. coli BL21(DE3)/ pETGAϩpUTaBE (10 7 CFU per fish), E. coli BL21(DE3)/pETGAϩpUTa (10 7 CFU per fish), purified GAPDH antigen with an equal volume of Freund's complete adjuvant (Sigma) (20 g per fish), or PBS (0.1 ml per fish) as a control. The fish were fed twice daily with commercial turbot feed and reared in aquaria supplied with a continuous flow of recycling water at 16 to 18°C. Four weeks after immunization, the four groups were injected i.p. with wildtype A. hydrophila LSA34 (5.0 ϫ 10 7 CFU per fish). Mortality was recorded for 12 days after challenge, and the observation of surviving fish was extended to 4 weeks. The significant difference and the relative percent survival (RPS) were calculated by using Fisher's exact test and the formula (46) RPS ϭ [1 Ϫ (% mortality in vaccinated fish/% mortality in control fish)] ϫ 100, respectively.
RESULTS

Screening for iron-regulated promoters.
To screen iron-regulated promoters for our system, a screening plasmid, pUTG, was constructed from pUC18 as shown in Fig. 1A . The GFP gene was taken as the reporter, the multicloning site adjacent to the GFP gene was used to insert the promoter sequence, and a strong rrnBT1T2 terminator derived from the rrnB rRNA operon of E. coli was placed downstream of the GFP gene to protect against read-through transcription. It was not necessary to introduce the fur gene (encoding the regulatory protein Fur, which is essential for iron-dependent promoters) into the screening plasmid pUTG, since the Fur protein is abundant, at 5,000 to 10,000 copies per E. coli cell, and is highly conserved in many Gram-negative and Gram-positive bacteria (66) . Thus, the chromosomal fur gene in the E. coli host was adequate to direct the synthesis of sufficient Fur repressor to repress the plasmid-located iron-regulated promoters.
Iron-dependent gene regulation mechanisms have been thoroughly studied in many different bacteria (39, 40, 45, 59) . Based on published reports, 23 candidate promoters were selected from the iron uptake, storage, and metabolism systems of four different bacteria, V. parahaemolyticus, V. cholerae, E. coli, and V. anguillarum; detailed information is shown in Table  3 . Each promoter was fused in frame with the GFP gene, and its transcription in LB medium supplemented with 40 M FeSO 4 (iron-rich medium) or 200 M 2,2Ј-dipyridyl (ironlimiting medium) was investigated. Samples were taken at defined times and adjusted to an OD 600 of 1 to measure the green fluorescence emitted by GFP, and the promoter strength and regulation could be simply correlated with the GFP fluores- 
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cence. Among all 23 candidate promoters, P suf , P fes , P huvA , P fhuA , and P viuB showed relatively high transcription activities, with relative fluorescence (RF) values of over 1,500 in ironlimiting medium (Fig. 1B and data not shown), and varied transcription strengths were demonstrated in iron-rich medium. Since strict regulation is a critical feature of an expression system when the recombinant protein is toxic to the host, it is crucial to limit target gene expression to basal levels until an inducer is added. The induction ratio is often used to evaluate the degrees of strict transcription control. Based on the data given in Fig. 1B , the induction ratios of P suf , P fes , P huvA , P fhuA , and P viuB were calculated as 11, 4, 3, 3, 11, and 195, respectively. Promoter P viuB , which showed both high transcription efficiency and tight regulatory control, was determined to be the best choice for iron-regulated expression of lysis gene E in E. coli. The P viuB origin gene viuB encodes a cytoplasmic protein necessary for ferric vibriobactin utilization in V. cholerae. By bioinformatics analysis, besides basic promoter elements of the transcriptional start site, Ϫ10 region, Ϫ35 region, and Shine-Dalgarno sequence, a potential Fur binding region was found around the Ϫ10 region in the promoter sequence, and the Fur box was believed to be the FurFe 2ϩ complex binding site for repressing transcription under iron-rich conditions (6) . To further confirm the existence of the Fur box in the P viuB sequence, a Fur titration assay was performed. As shown in Fig. 1C , the colonies of the negativecontrol strain E. coli H1717/pMD19T were colorless; however, E. coli H1717/pMD19TB showed a red colony phenotype when grown on MacConkey medium with 25 M FeSO 4 . This means that the P viuB sequence contains a Fur binding region, which could compete the Fur-iron complex with the fhuF promoter to derepress transcription of the lacZ gene. P viuB transcription in zebrafish. Since free iron is limited in vivo, we wanted to determine whether P viuB could sense the iron limitation signal in an animal host and initiate the target Compared with the positive control, basically no positive GFP signal was detected in both E. coli BL21(DE3)/pUTG and E. coli BL21(DE3)/pUTBG during the process of in vitro immersion, indicating that GFP synthesis could not be induced in the immersion solution ( Fig. 2A) . For testing the in vivo-responsive transcription of P viuB , transparent zebrafish larvae were used as the animal model. The fish were immersed in a cell suspension containing 10 8 CFU/ml of recombinant E. coli BL21(DE3)/pUTBG or E. coli BL21(DE3)/pUTG and examined at regular intervals using an inverted fluorescence microscope at a magnification of ϫ20. As shown in Fig. 2B , compared with the control E. coli BL21(DE3)/pUTG, which showed only a negative background fluorescence in zebrafish (Fig. 2B, panel I ), E. coli BL21(DE3)/ pUTGB resulted in strong fluorescence signal in the fish gastrointestinal tract and also weaker fluorescence signals around the skin mucosa and the gill sites at 9 h postinfection (Fig. 2B,  panel II) . These results suggested that P viuB could respond to the iron-limiting signal in vivo in zebrafish to initiate the GFP expression. Under this condition, it is most possible that the entry of E. coli into the gastrointestinal tract depends on host activities such as drinking of the water or ingestion. In addition, the gills and the skin are also the sites for bacterial entrance into the fish host (48) . For further observation, the fish sample was transferred to a confocal microscope, and the front, middle, and rear parts of the fish are displayed in Fig.  2B , panels III to V. Under a magnification of ϫ1,000, an obvious fluorescence signal was detected in the gastrointestinal tract (Fig. 2B, panel VI) . Taken together, these results indicate that P viuB is an efficient and strictly regulated promoter that is responsive to iron signals both in vitro and in vivo, indicating potential in establishing an in vivo-inducible bacterial lysis system.
Iron-regulated E. coli lysis in vitro. For achieving iron-regulated E. coli lysis, the X174 gene E, as an E. coli-sensitive lysis factor, was placed under transcriptional control of P viuB and inserted into the medium-copy-number number plasmid pUTa to yield pUTaBE. The lysis behavior of BL21(DE3)/ pUTaBE was analyzed in a 30-ml liquid culture. As shown in Fig. 3A , during the 2-h induction, the OD 600 value of BL21(DE3)/pUTaBE cell cultures rapidly declined nearly to zero, and correspondingly the viable cell number dropped from 10 9 CFU/ml to 10 5 CFU/ml, with a calculated lysis ratio of 99.99% Ϯ 0.01%. The control strain BL21(DE3)/pUTa grown with 2,2Ј-dipyridyl and strain BL21(DE3)/pUTaBE grown without 2,2Ј-dipyridyl displayed normal cell growth. Further, electron microscopy observation showed a regular cellular morphology of BL21(DE3)/pUTa (Fig. 3B, panel I ) in the presence of 2,2Ј-dipyridyl, indicating that the inducer 2,2Ј-dipyridyl itself did not influence cell growth or cause cell lysis. In the absence of 2,2Ј-dipyridyl, a few BL21(DE3)/pUTaBE cells were longer than normal under electron microscopy (Fig.  3B, panel II) . The cause for this phenomenon might be that the trace amount of E protein from leaky expression might inhibit cell division to some extent, since E-mediated lysis depends on cell division activities of E. coli (64) . In contrast, many of the BL21(DE3)/pUTaBE cells had lysed by 30 min after induction (Fig. 3B, panel III) , and nearly all the E. coli cells collapsed into cell debris by 2 h postinduction (Fig. 3B, panel IV) . All the results confirmed that the promoter P viuB could control the transcription of lysis gene E and efficiently lyse the E. coli host in an iron-responsive manner.
Antigen release based on iron-regulated E. coli lysis in vitro. A. hydrophila is a well-known fish pathogen all over the world (61) , and the GAPDH protein of A. hydrophila has been shown to be a protective antigen in fish (67) . The gapA gene, encoding A. hydrophila GAPDH, was cloned into the T7-based pET28a expression plasmid to construct a highly efficient antigen ex- BL21(DE3)/pUTBG (white bars) was induced to synthesize GFP as a positive control. Immersion solution was prepared as phosphate-buffered saline (PBS) with 1% bovine serum albumin. (B) Visualization of GFP synthesis under the control of P viuB in zebrafish by fluorescence microscopy. Fish were immersed in bacterial suspensions (10 8 CFU/ ml) of BL21(DE3)/pUTG (panel I) and BL21(DE3)/pUTBG (panel II) for 1 h and detected at 9 h postinfection. For further analysis, zebrafish infected by BL21(DE3)/pUTBG were observed by confocal microscopy. Panels III, IV, and V, different parts of the fish from head to tail, respectively (magnification, ϫ400); panel VI, details of the site marked by a box in panel IV (magnification, ϫ1,000).
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pression plasmid, pETGA. E. coli host BL21(DE3) was transformed with both pETGA and pUTaBE to result in a recombinant two-plasmid system which possessed both an ironregulated lysis circuit and an IPTG-inducible high-level antigen expression cassette, located in pUTaBE and pETGA, respectively (Fig. 4A ). These two plasmids have different origins of replication, p15A ori and pBR322 ori, which are compatible origins and could coexist in one cell (32) .
The recombinant E. coli strains BL21(DE3)/pETGAϩpUTaBE and BL21(DE3)/pETGAϩpUTa were induced to synthesize GAPDH for 5 h, and then the cultures were subcultured in a shaker to obtain an initial OD 600 of 0.1. At early log phase (OD 600 ϭ 0.3 to 0.4), 2,2Ј-dipyridyl was added to cultures to induce cell lysis. Under identical culture and induction conditions, similar amounts of GPADH were produced by the two strains. However, the control strain BL21(DE3)/ pETGAϩpUTa grew normally (Fig. 4B ) in iron-limiting medium, and 17% of the total GAPDH was detected in the cell supernatant fraction (Fig. 4C) , while the lysis strain BL21(DE3)/pETGAϩpUTaBE responded to the signal of iron limitation in medium and rapidly lysed (Fig. 4B) , indicating that expression of the E gene had occurred. After 2 h of induction, over 90% of the total GAPDH was released to the supernatant (Fig. 4C) . Here the total GAPDH was calculated as the sum of the GAPDH from the supernatant and the pellet for each culture. This result revealed that the integration of the iron-regulated lysis circuit and the IPTG-inducible high-level antigen expression cassette in E. coli BL21(DE3) could achieve mass production and controllable release of antigen.
Bacterial lysis and antigen release in zebrafish. To evaluate bacterial lysis and controlled antigen release in vivo, adult zebrafish were used as the animal model. After 5 h of IPTG induction of gapA expression, the recombinant E. coli BL21(DE3)/pETGAϩpUTaBE and BL21(DE3)/ pETGAϩpUTa were injected i.p. into zebrafish. Fish tissues were sampled at 4, 9, and 24 h postadministration and prepared for subsequent assay.
To determine the growth and lysis of E. coli in vivo, the fish samples were plated on LB screening agar for viable cell counts. As shown in Fig. 5A , at 4 h after injection, the numbers of BL21(DE3)/pETGAϩpUTaBE and BL21(DE3)/ pETGAϩpUTa cells were roughly equivalent. At later times, the numbers of BL21(DE3)/pETGAϩpUTa cells increased and then remained at between 10 4 CFU/fish and 10 5 CFU/fish, while the numbers of BL21(DE3)/pETGAϩpUTaBE cells sharply decreased from 9 h and no survivors were recovered after 24 h. This result suggested that the P viuB -controlled E gene was transcribed in vivo and the E protein lysed the E. coli to achieve biological containment.
Fish tissue samples were further analyzed by Western blotting to detect GAPDH released from the E. coli cells. As shown in Fig. 5B, at 4, 9 , and 24 h, no GAPDH from BL21(DE3)/pETGAϩpUTa (no protein E) was detected in homogenized samples, which indicated that the expressed GAPDH was retained mainly in the cytoplasm, since the conditions used to homogenize the fish tissues do not lyse the bacterial cells. In contrast, GAPDH from BL21(DE3)/ pETGAϩpUTaBE (protein E synthesized) was detected in homogenized samples and increased with time. The timeresponsive pattern of antigen release in fish injected with BL21(DE3)/pETGAϩpUTaBE coincided with that of bacterial lysis as described above (Fig. 5B) , indicating that E-mediated E. coli lysis resulted in antigen release in vivo.
Immune protection evaluation in turbot. To investigate the potential of the E-mediated antigen delivery and release system in a live bacterial vectored vaccine, the recombinant strain BL21(DE3)/pUTaBEϩpETGA was used as the vaccine candidate for further evaluation of immune protection efficacy in turbot. The fish were injected i.p. with the vaccine strains, purified GAPDH, or PBS and challenged with pathogenic A. hydrophila LSA34 at 30 days postvaccination. Most of the fish that died displayed typical abdominal distension, internal hemorrhages, and skin ulcerations at the injection site. No external lesions were observed in the surviving fish. Challenge of the PBS-injected control group resulted in 96.7% mortality. As shown in Fig. 6 , candidate vaccine BL21(DE3)/ pETGAϩpUTaBE and purified GAPDH provided similar levels of protection, with RPSs of 82% and 72%, respectively, which were significantly greater than that of BL21(DE3)/ pETGAϩpUTa (RPS of 31%; P Ͻ 0.005).
Through live E. coli vector-based antigen delivery and release in animal host, the passenger antigen could confer a protective immune response equivalent to that of purified antigen with adjuvant. In the strain without the lysis-based antigen release system pUTaBE, the recombinant E. coli expressing gapA could not evoke effective immune protection (RPS ϭ 31%; P Ͻ 0.005), indicating that the controllable mass release of antigen, initially produced by the bacterial vector into the host in the form of a cytoplasmic protein, would facilitate access of antigen to the immunerelated cells and in turn promote a protective immune response in the animal host.
DISCUSSION
In this work, a novel live bacterial vector system for antigen delivery was established. As illustrated in Fig. 7 (20 g per fish) , or PBS as a control (0.1 ml per fish). Four weeks after immunization, the four groups were injected i.p. with wild-type A. hydrophila LSA34 (5.0 ϫ 10 7 CFU per fish). The significant difference and the relative percent survival (RPS) were calculated by using Fisher's exact test and the formula RPS ϭ [1 Ϫ (% mortality in vaccinated fish/% mortality in control fish)] ϫ 100, respectively.
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on November 11, 2017 by guest http://iai.asm.org/ gous protective antigen was produced under the control of the strong promoter P T7 and synthesis of the E coli-sensitive lysis protein E was tightly regulated by the iron-responsive promoter P viuB . When cultured in vitro in an iron-rich medium, the recombinant E. coli could grow normally, with the cytoplasmic synthesis of antigen and the repression of lysis gene E by the Fur-iron complex (Fig. 7A) ; when administrated to the host, the recombinant E. coli could initiate the synthesis of lysis protein E in response to the iron-limiting signal in vivo and lyse to release the antigen in the host, simultaneously conferring biological containment (Fig. 7B) . As a live bacterial delivery system, the E. coli-based antigen delivery system combines features of highly efficient antigen production, controlled antigen release, and active biological containment. Based on iron-dependent gene regulation mechanisms in different bacteria, several novel iron-regulated cassettes have been constructed. The fhuCDB operon of V. cholerae is involved in ferrichrome iron utilization and is part of the Fur regulon. The promoter of the fhuCDB operon, P fhuC showed transcription activity in V. cholerae vaccine strain CVD and was identified to be an in vivo-inducible promoter in a mouse model by real-time bioluminescent imaging (42) . The promoter of the fecA2 gene, encoding an 88-kDa iron(III) dicitrate transport protein in Helicobacter pylori, was identified to regulate iron-responsive transcription of the reporter gene of luciferase (25) . The P entC promoter of the entCEBA operon, encoding enzymes for enterobactin biosynthesis in E. coli, was applied to an iron chelator-inducible expression system (34) . In this work, an iron-regulated promoter, P viuB , with strict regulation and efficient transcription was successfully identified, and more importantly, the P viuB controlled iron-regulated cassette was shown to function well not only in vitro but also in vivo in two animal hosts, indicating that this promoter can function as part of an in vivo-inducible expression system. In addition, the P viuB -type promoter may have other applications as an iron availability biosensor in the food industry and for environmental and industrial monitoring.
Another key factor in our E. coli-based antigen delivery system is the lysis gene E. According to previous reports, under the control of either the thermosensitive pL/pR-cI857 promoter or chemical-inducible promoter repressor systems such as lacPO or the tol expression system, protein E typically lyses E. coli by forming transmembrane tunnels specifically at the areas of potential division sites and expelling the inner contents to produce intact cell envelopes, called bacterial ghosts (38) . However, the P viuB -controlled E lysis in this work lysed the bacterial cells into debris, which may be more conducive for antigen release, and this may be attributed to the dual roles of E protein and iron-limiting conditions in cells. Since the iron-limiting condition is a specific signal not only in vivo but also in the environment, the P viuB -controlled E lysis system has the potential to be developed into an active biological containment system for genetically engineered E. coli or other bacteria in agriculture, waste treatment, and the food industry, where large quantities of cells may need to be introduced into the environment or biological hosts.
The promoter P T7 -controlled expression systems based on bacteriophage T7 RNA polymerase are often the optimal choice for the high-level production of recombinant proteins (19) . In this work, the P T7 -controlled antigen expression was integrated with P viuB -regulated bacterial lysis into a recombinant system which actualized high-level antigen expression in vitro and mass antigen release in a vaccinated host to elicit efficient protective immune responses against lethal challenge. In addition, the integrated antigen delivery system is believed to be superior to general bacterium-based antigen surface display or secretion systems in which most of the expressed antigen is retained in the cell cytoplasm. Furthermore, this recombinant system could be modified to suit a number of different needs for antigen or other functional protein delivery in organisms.
Via i.p. injection vaccination, the E. coli-based recombinant system could effectively deliver and release antigen into the fish host and thus activate immune protection in turbot against lethal challenge. However, by immersion vaccination, only trace amounts of antigen were detected in the homogenized samples of fish gill, intestine, and skin mucus (data not shown), which coincided with the poor immune protection (RPS of Ͻ10%) observed in turbot. The reason that the recombinant E. coli vector vaccine failed in mucosal vaccination might lie in the fact that E. coli BL21(DE3) is a nonpathogenic and noninvasive bacterium for turbot and therefore was unable to efficiently reach the immune-inductive sites of fish via mucosal routes. Therefore, to extend the application of this antigen FIG. 7 . A novel antigen delivery and release system in E. coli. (A) Iron-rich conditions. In iron-rich medium, the iron-Fur complex binds to the Fur box of P viuB and represses the transcription of the E gene, while the antigen gene is expressed under control of the IPTG-inducible T7 promoter. (B) Iron-limiting conditions. In the host organism, antigen gene expression is repressed by LacI in the absence of IPTG. Meanwhile the iron-Fur complex is dissociated and the transcription of the E gene initiated. Bacterial cells are rapidly lysed by protein E to achieve antigen release and biological containment.
delivery and cell lysis system as an effective mucosal vaccine, bacterial hosts with more proficiency in invasion and colonization need to be selected or established in the future.
In this work, we constructed a novel platform for a recombinant vaccine and evaluated its feasibility as a fish vaccine. If this platform is expanded to be used as a mammalian vaccine in the future, the two-plasmid system needs to be further optimized in many aspects, such as using a single plasmid to express the antigen and lysis gene cassettes, replacing the antibiotic marker with the balanced-lethal vector system, or integrating the expression cassettes into the chromosome of the bacterial host. Besides that, the protective antigens from mammalian pathogens need to be screened and applied in this platform for a mammalian vaccine; simultaneously some attenuated bacteria derived from mammalian pathogens can be tested to replace E. coli as the bacterial vector, and the vector bacteria need to be further modified to reduce the putative inflammatory response evoked in the mammalian host. The route of administration of a bacterial vector vaccine in a mammalian host depends on the features of the vector bacteria. Moreover, we believe that this technology could also be applied to many other Gram-negative bacteria which are sensitive to the E gene.
